These adverse reactions have a significant negative impact on the patient’s quality of life with 75% of respondents who experienced a current rash reporting the rash had an extremely significant or very large effect on their quality of life.
← all excerpts
Navigating metastatic colorectal treatment options in the USA: a survey of patient acceptance of skin toxicities associated with Vectibix.
1
—
—